| 9 | $ARXRF News Article - Infinite Ore Announces | whytestocks | 02/17/2021 11:35:48 AM |
| 8 | ARXRF Financials 07/16/2014 03:38:23 Alix | Emylers | 07/16/2014 4:38:20 AM |
| 7 | Latest Alix Res Corp (ARXRF) Headlines Focus Gold | Stock_Tracker | 03/08/2014 10:26:22 PM |
| 6 | Latest Alix Res Corp (ARXRF) Headlines Focus Gold | Stock_Tracker | 03/08/2014 10:00:04 PM |
| 5 | Latest Alix Res Corp (ARXRF) Headlines Focus Gold | Stock_Tracker | 03/08/2014 9:31:32 PM |
| 4 | ARXRF 0.0247 Stock Charts $ARXRF 1 Month Chart | chartguy89 | 03/05/2014 11:18:30 PM |
| 3 | ARXRF Recent News Focus Gold Sees Potential for a | Stock_Tracker | 03/02/2014 5:44:30 PM |
| 2 | ARXRF Stock Charts Saturday, February 22, 2014 at | chartguy89 | 02/22/2014 11:46:36 PM |
| 1 | Alix Resources Corp To Acquire 220 Acre Homestake | Lmcat | 12/28/2012 10:09:19 AM |
Recent Articles
- CARsgen's Innovative CT0596 Therapy Shows Promise in Trials
- HUTCHMED Expands Coverage of Innovative Drugs in China
- ChemLex Secures $45M to Revolutionize Drug Discovery Tech
- ElevenLabs Innovates Hollywood: AI Voice Cloning Revolution
- How Avantor, Inc. Investors Can Take Action on Losses
- Mitsubishi Electric Joins Linux Foundation As Gold Member
- Respiree's AI Software Gains HSA Approval for Patient Monitoring
- ChemLex Secures $45 Million to Revolutionize Drug Discovery
- ALLUONE Introduces Innovative Smart Garden for Urban Homes
- Exploring Open Source in Japan: Opportunities and Challenges
- ChemLex Secures $45 Million Overhaul for Drug Discovery Lab
- CarMax, Inc. Investors Urged to Join Class Action Lawsuit
- Immix Biopharma Achieves Landmark Phase 2 Success with NXC-201
- Immix Biopharma's Strategic $100 Million Stock Offering Explained
- Structure Therapeutics Unveils Upcoming Data from ACCESS Program
- Crypto’s ETF Wave and The New Investment Gateway Beyond Bitcoin
- Matthews International Strategically Navigates Market Challenges
- Positive Results from SELLAS Life Sciences' SLS009 Phase 2 Study
- BeOne Medicines Celebrates Progress of Sonrotoclax in CLL Treatment
- Investors Rally: Join Class Action Against James Hardie Industries
- Transforming Crypto Trading: Anchorage Digital's Partnership
- ImCheck Showcases Promising Efficacy of ICT01 in AML Trials
- Lime & Lemon Apex: A Game-Changer in Collective Dining
- Exciting Developments in Chibougamau Copper-Gold Project
- Analyzing China's Military Advancements and Global Impact
- Rosen Law Firm Investigates Potential Claims for Aglion Health Investors
- Lyell Immunopharma Unlocks Promising Results for Ronde-Cel
- Lynozyfic™ Shows Potential as Frontline Treatment for Myeloma
- Promising Results in Lyell Immunopharma's Ronde-Cel Trial
- Eli Lilly's Jaypirca Achieves Key Milestone in Latest Study
- How Leading Tech Companies Maintain Dominance with Automation
- Wave Life Sciences Set to Reveal Key Trial Data for Obesity
- Embracing Work-Life Balance: A Shift in Employee Priorities
- Power of Attorney Attestation Dubai: Legal Use Cases and Process Guide
- Transforming Investor Mindsets: The Power of Just $1
- Hidden Project Risks That Can Ruin Your Timeline and How To Prevent Them
- Apple Facing Leadership Changes Amid AI Development Concerns
- Elderly Victim's Heartbreaking Loss in Crypto ATM Scam
- Replicor's Innovative Approach to Treating HBV and HDV Infections
- Sundar Pichai on AI Revolutionizing Decisions from Finance to Health
- Prologis to Redeem 3.00% Notes Ahead of 2026 Maturity
- Prologis to Redeem Outstanding Bonds Ahead of Schedule
- Exploring the Sinister Connections of Russian Cyber Attacks
- How Russia Has Embraced Bitcoin Amidst Economic Challenges
- China's International Supply Chain Expo: A Gateway to Global Trade
- Retail Traders Innovate Investment with Discord-Backed Fund
- Nexon CEO Comments on AI's Role Amidst Industry Concerns
- Trump Defends White House Ballroom Project Against Criticism
- Air Transat's Challenges: A Call for Urgent Management Changes
- Uncovering Ulta Beauty's Ascendance to an $11 Billion Dynasty
